ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
62.19
+0.84 (1.37%)
At close: Jul 19, 2024, 4:30 PM
62.20
+0.01 (0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

ANI Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1997
Revenue
517.46486.82316.39216.14208.48206.55
Upgrade
Revenue Growth (YoY)
44.26%53.87%46.38%3.67%0.93%2.47%
Upgrade
Cost of Revenue
192.96181.51138.79100.6187.1663.15
Upgrade
Gross Profit
324.5305.3177.6115.53121.32143.39
Upgrade
Selling, General & Admin
173.25161.7124.0484.2964.9955.84
Upgrade
Research & Development
38.8734.2922.3211.371619.81
Upgrade
Other Operating Expenses
54.5661.0862.0963.556.8451.62
Upgrade
Operating Expenses
266.68257.07208.46159.16137.83127.27
Upgrade
Operating Income
57.8248.24-30.86-43.64-16.5116.12
Upgrade
Interest Expense / Income
23.8426.9428.0511.929.4512.97
Upgrade
Other Expense / Income
-9.071.433.760.5--
Upgrade
Pretax Income
43.0419.87-62.67-56.06-25.963.16
Upgrade
Income Tax
7.51.09-14.77-13.46-3.41-2.94
Upgrade
Net Income
35.5518.78-47.9-42.6-22.556.09
Upgrade
Preferred Dividends
1.631.631.630.1900
Upgrade
Net Income Common
33.9217.15-49.52-42.79-22.556.09
Upgrade
Net Income Growth
------60.67%
Upgrade
Shares Outstanding (Basic)
191816131212
Upgrade
Shares Outstanding (Diluted)
191816131212
Upgrade
Shares Change
17.49%11.89%29.09%5.28%-0.63%2.28%
Upgrade
EPS (Basic)
1.620.86-3.05-3.40-1.880.51
Upgrade
EPS (Diluted)
1.580.85-3.05-3.40-1.880.50
Upgrade
EPS Growth
------61.54%
Upgrade
Free Cash Flow
118.22110.09-39.333.419.1339
Upgrade
Free Cash Flow Per Share
6.096.05-2.420.270.763.24
Upgrade
Gross Margin
62.71%62.71%56.13%53.45%58.19%69.42%
Upgrade
Operating Margin
11.17%9.91%-9.75%-20.19%-7.92%7.81%
Upgrade
Profit Margin
6.56%3.52%-15.65%-19.80%-10.82%2.95%
Upgrade
Free Cash Flow Margin
22.85%22.61%-12.43%1.58%4.38%18.88%
Upgrade
Effective Tax Rate
17.41%5.50%----93.03%
Upgrade
EBITDA
128.31107.8725.043.1228.1360.74
Upgrade
EBITDA Margin
24.80%22.16%7.91%1.44%13.49%29.40%
Upgrade
Depreciation & Amortization
61.4261.0659.6547.2544.6444.61
Upgrade
EBIT
66.8946.81-34.61-44.14-16.5116.12
Upgrade
EBIT Margin
12.93%9.62%-10.94%-20.42%-7.92%7.81%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).